268 related articles for article (PubMed ID: 20116342)
1. A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant.
Zhang H; Martin D; Chiu-Tsao ST; Meigooni A; Thomadsen BR
Brachytherapy; 2010; 9(4):362-72. PubMed ID: 20116342
[TBL] [Abstract][Full Text] [Related]
2. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
3. COMS eye plaque brachytherapy dosimetric sensitivity to source photon energy and seed design.
Gagne NL; Rivard MJ
Appl Radiat Isot; 2013 Sep; 79():62-6. PubMed ID: 23728350
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 16 mm OSU-Nag and COMS eye plaques.
Zhang H; Davidorf F; Qi Y
J Appl Clin Med Phys; 2012 May; 13(3):3632. PubMed ID: 22584165
[TBL] [Abstract][Full Text] [Related]
5. [Brachytherapy of ocular melanoma: physical and dosimetric aspects of 125I plaques].
Bard JJ
Bull Cancer Radiother; 1995; 82(3):295-305. PubMed ID: 8554879
[TBL] [Abstract][Full Text] [Related]
6. Improved treatment planning for COMS eye plaques.
Astrahan MA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
[TBL] [Abstract][Full Text] [Related]
7. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
Gagne NL; Leonard KL; Rivard MJ
Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
10. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
Melhus CS; Rivard MJ
Med Phys; 2008 Jul; 35(7):3364-71. PubMed ID: 18697560
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
12. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
[TBL] [Abstract][Full Text] [Related]
13. Perturbation of TG-43 parameters of the brachytherapy sources under insufficient scattering materials.
Zehtabian M; Sina S; Faghihi R; Meigooni A
J Appl Clin Med Phys; 2013 May; 14(3):4228. PubMed ID: 23652255
[TBL] [Abstract][Full Text] [Related]
14. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
[TBL] [Abstract][Full Text] [Related]
15. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
Lee YC; Lin SC; Kim Y
Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
[TBL] [Abstract][Full Text] [Related]
16. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric study of the 15 mm ROPES eye plaque.
Granero D; Pérez-Calatayud J; Ballester F; Casal E; de Frutos JM
Med Phys; 2004 Dec; 31(12):3330-6. PubMed ID: 15651616
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
Miras H; Terrón JA; Lallena AM
Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
[TBL] [Abstract][Full Text] [Related]
19. Investigating the dosimetric impact of seed location uncertainties in Collaborative Ocular Melanoma Study-based eye plaques.
Johnson JE; Deufel CL; Furutani KM
Brachytherapy; 2016; 15(5):661-8. PubMed ID: 27475484
[TBL] [Abstract][Full Text] [Related]
20. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
